InsiderClue
Stocks · Health care · Pharmaceutical Preparations

PLIANT THERAPEUTICS, INC.

PLRX Clue Score31
United States Fiscal year ends December CIK 0001746473
$1.02 +2.00% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $1.02 −94.25% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 3 Jun 2020. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2019Revenue57.1Operating income−1.2Net income−0.6EPS, diluted−4.22Fiscal year 2020Revenue41.8 −26.7%Operating income−41.6Net income−41.5EPS, diluted−1.95Fiscal year 2021Revenue7.6 −81.9%Operating income−97.5Net income−97.3EPS, diluted−2.71Fiscal year 2022Revenue9.7 +27.9%Operating income−127.2Net income−123.3EPS, diluted−2.94Fiscal year 2023Revenue1.6 −83.7%Operating income−184.1Net income−161.3EPS, diluted−2.75Fiscal year 2024Revenue0.0 −100.0%Operating income−228.4Net income−210.3EPS, diluted−3.47Fiscal year 2025Revenue0.0Operating income−156.4Net income−149.3EPS, diluted−2.43
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 57.1 41.8 7.6 9.7 1.6 0.0 0.0
Growth −26.7% −81.9% +27.9% −83.7% −100.0%
Operating income −1.2 −41.6 −97.5 −127.2 −184.1 −228.4 −156.4
Net income −0.6 −41.5 −97.3 −123.3 −161.3 −210.3 −149.3
Growth
EPS, diluted −4.22 −1.95 −2.71 −2.94 −2.75 −3.47 −2.43

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2019Operating margin−2.2%Net margin−1.1%Free cash flow margin−6.5%Fiscal year 2020Operating margin−99.6%Net margin−99.3%Free cash flow margin−92.8%Fiscal year 2021Operating margin−1,288.1%Net margin−1,284.5%Free cash flow margin−1,022.1%Fiscal year 2022Operating margin−1,313.4%Net margin−1,273.3%Free cash flow margin−995.3%Fiscal year 2023Operating margin−11,654.7%Net margin−10,211.1%Free cash flow margin−7,422.9%Fiscal year 2024Fiscal year 2025
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −2.2% −99.6% −1,288.1% −1,313.4% −11,654.7% n/a n/a
Net margin −1.1% −99.3% −1,284.5% −1,273.3% −10,211.1% n/a n/a
Free cash flow margin −6.5% −92.8% −1,022.1% −995.3% −7,422.9% n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2019Operating cash flow−2.8Capital expenditure−1.0Free cash flow−3.7Fiscal year 2020Operating cash flow−37.3Capital expenditure−1.5Free cash flow−38.8Fiscal year 2021Operating cash flow−75.4Capital expenditure−2.0Free cash flow−77.4Fiscal year 2022Operating cash flow−94.6Capital expenditure−1.8Free cash flow−96.4Fiscal year 2023Operating cash flow−116.4Capital expenditure−0.9Free cash flow−117.3Fiscal year 2024Operating cash flow−155.5Capital expenditure−3.8Free cash flow−159.4Fiscal year 2025Operating cash flow−128.3Capital expenditure−0.4Free cash flow−128.7
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −2.8 −37.3 −75.4 −94.6 −116.4 −155.5 −128.3
Capital expenditure −1.0 −1.5 −2.0 −1.8 −0.9 −3.8 −0.4
Free cash flow −3.7 −38.8 −77.4 −96.4 −117.3 −159.4 −128.7
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2019Cash85.8Shareholders’ equity−76.3Fiscal year 2020Cash50.9Shareholders’ equity283.1Fiscal year 2021Cash51.7Total debt0.0Net cash (debt)51.7Shareholders’ equity199.1Debt to equity0.00Fiscal year 2022Cash33.7Total debt9.9Net cash (debt)23.8Shareholders’ equity313.3Debt to equity0.03Fiscal year 2023Cash63.2Total debt10.1Net cash (debt)53.2Shareholders’ equity473.6Debt to equity0.02Fiscal year 2024Cash71.2Total debt30.2Net cash (debt)41.0Shareholders’ equity304.1Debt to equity0.10Fiscal year 2025Cash45.4Total debt0.0Net cash (debt)45.4Shareholders’ equity181.2Debt to equity0.00
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 85.8 50.9 51.7 33.7 63.2 71.2 45.4
Total debt n/a n/a 0.0 9.9 10.1 30.2 0.0
Net cash (debt) n/a n/a 51.7 23.8 53.2 41.0 45.4
Shareholders’ equity −76.3 283.1 199.1 313.3 473.6 304.1 181.2
Debt to equity n/a n/a 0.00 0.03 0.02 0.10 0.00

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2019 31 Dec 2019 FY2020† 31 Dec 2020 FY2021† 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
57.1 41.8 7.6 9.7 1.6 0.0 0.0
Growth −26.7% −81.9% +27.9% −83.7% −100.0%
47.4 66.2 77.5 96.9 127.8 169.3 109.2
10.9 17.3 27.6 39.9 57.9 59.1 47.2
−1.2 −41.6 −97.5 −127.2 −184.1 −228.4 −156.4
Growth
0.0 0.0 0.0 0.0 0.0 0.0 0.0
−0.6 −41.5 −97.3 −123.3 −161.3 −210.3 −149.3
Growth
Per share
−4.22 −1.95 −2.71 −2.94 −2.75 −3.47 −2.43
−4.22 −1.95 −2.71 −2.94 −2.75 −3.47 −2.43
Growth
1.6 21.3 35.8 42.0 58.7 60.5 61.4
1.6 21.3 35.8 42.0 58.7 60.5 61.4
Growth +1,214.8% +67.9% +17.2% +39.8% +3.1% +1.4%

† The diluted share count jumps at 2020 and 2021, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 7 of 7 years on file.